Clinical Trial: A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07692165) titled 'A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis' on June 23.

Brief Summary: A Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants with Active Ulcerative Colitis.

The study aims to evaluate the safety, efficacy, pharmacokinetic (PK) characteristics, pharmacodynamic (PD) characteristics of INT-210 in participants with active ulcerative colitis (UC).

Study Start Date: June 11

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: INT-210 Capsule

All participants will receive oral treatment wi...